Actively Recruiting

Phase 2
Age: 18Years - 69Years
All Genders
NCT06847191

NE3107 in Adults With Neurological Symptoms of Long COVID

Led by BioVie Inc. · Updated on 2026-02-19

208

Participants Needed

20

Research Sites

65 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in people with Long COVID including difficulty concentrating or remembering things ("brain fog") and fatigue. Researchers will compare NE3107 to a placebo (a look-alike substance that contains no drug) to see if NE3107 works to treat neurocognitive and fatigue symptoms of long COVID. Participants will: * Take NE3107 or a placebo twice daily for 84 days * Visit the clinic 5 times for checkups and tests and have a follow up phone call

CONDITIONS

Official Title

NE3107 in Adults With Neurological Symptoms of Long COVID

Who Can Participate

Age: 18Years - 69Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 69 years
  • Long COVID with neurological symptoms including fatigue and neurocognitive impairment starting or worsening after a COVID-19 infection at least 3 months before screening
  • Symptoms lasting for at least 3 months
  • Symptoms not explained by other conditions as judged by the investigator
  • Agree to keep other regular medications at current doses during the study unless medically necessary to change
  • Agree to use birth control methods
  • Provide voluntary consent
  • Willing to allow blood collection
  • Pass all screening tests and procedures
Not Eligible

You will not qualify if you...

  • Received a COVID-19 vaccination within 14 days prior to screening
  • Previous admission to intensive care unit for COVID-19
  • History of major mental or physical illness before COVID-19 infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 20 locations

1

Stanford University

Palo Alto, California, United States, 94304

Actively Recruiting

2

UCSF

San Francisco, California, United States, 94110

Actively Recruiting

3

University of Colorado

Aurora, Colorado, United States, 80045

Actively Recruiting

4

Yale University

New Haven, Connecticut, United States, 06519

Actively Recruiting

5

Clinical Trial Site

Jacksonville, Florida, United States, 32258

Actively Recruiting

6

Centricity Research

Columbus, Georgia, United States, 31904

Actively Recruiting

7

Illinois Research Network University of Illinois at Chicago

Chicago, Illinois, United States, 60608

Actively Recruiting

8

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

9

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

10

Norton Infectious Disease Institute

Louisville, Kentucky, United States, 40202

Actively Recruiting

11

Jadestone Clinical Research

Silver Spring, Maryland, United States, 20904

Actively Recruiting

12

Clinical Trial Site

Farmington Hills, Michigan, United States, 48334

Actively Recruiting

13

Mayo Clinic

Rochester, Minnesota, United States, 55905

Actively Recruiting

14

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

15

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States, 44106

Actively Recruiting

16

Zenos Clinical Research

Dallas, Texas, United States, 75230

Actively Recruiting

17

University of Texas health Science Center at San Antonio

San Antonio, Texas, United States, 78229

Actively Recruiting

18

Chronicle Bio Inc.

Park City, Utah, United States, 84119

Actively Recruiting

19

Swedish Center for Research and Innovation

Seattle, Washington, United States, 98104

Actively Recruiting

20

West Virginia University

Morgantown, West Virginia, United States, 26506

Actively Recruiting

Loading map...

Research Team

P

Penelope Markham, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

NE3107 in Adults With Neurological Symptoms of Long COVID | DecenTrialz